Latest filing published 08 Apr 2024 for NGM Biopharmaceuticals INC.
Insider track record
No signal scores available.
Valerie L. Pierce: trading record in brief
Valerie L. Pierce is a declared insider of NGM Biopharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 2 March 2023 to 5 April 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 8 April 2024 came the latest disclosure, a transaction in NGM Biopharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Valerie L. Pierce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 26,458 sharesCommon StockSEC:0000950170-24-042625:0
- 5,021 shares@ US$1.34100.0% of flowCommon StockSEC:0001415889-24-001542:0
- 49,000 shares0Common StockSEC:0001209191-23-016377:0
3 of 3 declarations